Skip to main content
SpringerLink
Log in

Galectin-3-Hemmung

Erste vielversprechende Studienergebnisse einer neuen Strategie bei IPF

  • Journalclub
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Nach Originalie

2

Nach Originalie

Literatur

  1. Mackinnon AC, Gibbons MA, Farnworth SL et al. Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3. Am J Respir Crit Care Med. 2012;185(5):537-46

  2. Partridge EA, Le Roy C, Di Guglielmo GM et al. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science. 2004;306(5693):120-4

  3. Nishi Y, Sano H, Kawashima T et al. Role of galectin-3 in human pulmonary fibrosis. Allergol Int. 2007;56(1):57-65

  4. Delaine T, Collins P, MacKinnon A et al. Galectin-3-Binding Glycomimetics that Strongly Reduce Bleomycin-Induced Lung Fibrosis and Modulate Intracellular Glycan Recognition. Chembiochem. 2016;17(18):1759-7

  5. MacKinnon AC, Farnworth SL, Hodkinson PS et al. Regulation of alternative macrophage activation by galectin-3. J Immunol. 2008;180(4):2650-8

Download references

Author information

Authors and Affiliations

  1. Herz-Thorax-Zentrum Fulda\/Klinikum Fulda, Pacelliallee 4, 36043, Fulda, Germany

    Philipp Markart

  2. Universitätsklinikum Gießen Marburg GmbH, Kliniksraße 36, 35392, Gießen, Germany

    Andreas Günther

Authors
  1. Philipp Markart
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andreas Günther
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philipp Markart.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Markart, P., Günther, A. Erste vielversprechende Studienergebnisse einer neuen Strategie bei IPF. Pneumo News 13, 21–23 (2021). https://doi.org/10.1007/s15033-021-2689-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-021-2689-9

Search

Navigation